SAVA

Cassava Sciences Inc
31.6873
0.1673 (0.53%)

Cassava Sciences Inc. (SAVA) Fundamentals

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.
SHARE INFORMATION
Market Cap$ 1,315,504,757
Shares Outstanding41,735,557
Float39,486,375
Percent Float94.61%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.82
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment CashCash
HOLDERS
Institutions325
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months1,070,657
Institutional Holdings Percent49.7%
Institutional Sold Previous 3 Months838,953
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months109,376
Insider Holdings Percent5.1
Insider Sold Previous 3 Months9,376
Insider Shares Owned2,110,804
TRADING INFO
52 Week High$ 62.49
52 Week Low$ 13.84
52 Week High Change$ -31.07
21 Day Moving Average$ 31.131
21 Day Extended Moving Average$ 30.9816
50 Day Moving Average$ 33.4298
50 Day Extended Moving Average$ 32.5583
200 Day Moving Average$ 29.5864
200 Day Extended Moving Average$ 33.7985
10 Day Average Volume2,983,835
20 Day Average Volume2,088,902
30 Day Average Volume1,820,256
50 Day Average Volume1,536,544
Alpha0.145935
Beta-0.0843
Standard Deviation0.628646
R20.000052
7 Day Price Change$ 3.61
7 Day Percent Change12.93%
21 Day Price Change$ -2.54
21 Day Percent Change-7.46%
30 Day Price Change$ 1.98
30 Day Percent Change6.7%
Month to Date Price Change$ 3.52
Month to Date Percent Change12.57%
Quarter to Date Price Change$ 1.98
Quarter to Date Percent Change6.7%
180 Day Price Change$ 12.14
180 Day Percent Change62.64%
200 Day Price Change$ 7.61
200 Day Percent Change31.83%
Year to Date Price Change$ 1.98
Year to Date Percent Change6.7%

Cassava Sciences Inc. (SAVA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book6.10
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio22.10
Leverage Ratio1.00
Quick Ratio21.00
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-16.10
Enterprise Value$ 1,027,486,041
Price to Sales0.00
Price to Free Cash-20.30
PE High Last 5 Years-4.00
Price To Book6.10
Price To Cash Flow0.00
PE Low Last 5 Years-26.90
Price to Tangible Book6.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-29.61
Return on Equity-30.58
Return on Capital-31.08

Cassava Sciences Inc. (SAVA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEORemi Barbier
Emplyoees24
Last AuditUQ
CIK0001069530
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address7801 N. Capital of Texas Highway
Suite 260
Austin, TX 78731
Websitehttps://www.cassavasciences.com
Facsimile+1 512 501-0414
Telephone+1 512 501-2444
EmailIR@cassavasciences.com


Your Recent History
NASDAQ
SAVA
Cassava Sc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.